EN PL
CASE REPORT
Seronegative spondyloarthropathy in the course of inflammatory bowel disease
 
More details
Hide details
 
Online publication date: 2011-12-28
 
 
Reumatologia 2011;49(6):450-455
 
KEYWORDS
ABSTRACT
Spondyloarthropathy associated with inflammatory bowel disease (IBD) is one of forms of seronegative spondyloarthropathies (SpA). Both groups of diseases may have common pathogenesis. In the course of IBD, in 20–50% of patients peripheral or axial arthritis is observed, while in 30–60% of patients with SpA microscopic gut inflammation can be diagnosed. This situation can lead to the diagnostic difficulties as it was shown in this paper with an example of a 25-year-old woman with a family history of IBD, history of peripheral arthritis and with signs of inflammatory back pain. Radiograms showed bilateral sacroiliitis (Fig. 1 and 2), no important changes in the spine (Fig. 3 and 4) and hips (Fig. 5). In endoscopy, the features of IBD were observed (asymptomatic). Finally, in our patient SpA associated with IBD was diagnosed. Examining SpA patients for gut inflammation is important because of prognostic and therapeutic implications.
REFERENCES (18)
1.
Przepiera-Będzak H, Brzosko M. Seronegatywne zapalenia stawów kręgosłupa (seronegatywne spondyloartropatie zapalne). W: Reumatologia. Puszczewicz M. (red.). Medical Tribune Pol­ska 2011; 247-248.  .
 
2.
Przepiera-Będzak H, Brzosko I. Zapalenie stawów w przebiegu nieswoistych chorób zapalnych jelit. W: Reumatologia. Puszczewicz M. (red.). Medical Tribune Polska 2011; 265-267.  .
 
3.
Van den Berg R, van der Heijde D. Jak rozpoznawać spondyloartropatię według kryteriów klasyfikacyjnych ASAS 2010 – przewodnik dla lekarzy praktyków. Medycyna Praktyczna 2011; 12: 58-69.  .
 
4.
Rudwaleit M, Landewé R, van der Heijde D. The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009; 68: 770-776.  .
 
5.
Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777-783.  .
 
6.
Rutkowska-Sak L, Słowińska I, Żuber Z. Młodzieńcze spondyloartropatie. Ann Acad Med Stetinensis 2010; 56, suppl 1: 29-33.  .
 
7.
Salvarani C, Fries W. Clinical features and epidemiology of spon­dyloarthritides associated with inflammatory bowel disease. World J Gastroenterol 2009; 15: 2449-2455.  .
 
8.
Orlando A, Renna S, Perricone G, et al. Gastrointestinal lesions associated with spondyloarthropathies. World J Gastroenterol 2009; 15: 2443-2448.  .
 
9.
Rodriguez-Reyna TS, Martinez-Reyes C, Yamamoto-Furusho JK. Rheumatic manifestations of inflammatory bowel disease. World J Gastroenterol 2009; 28: 5517-5524. .
 
10.
Zawadzka P, Hrycaj P. Artropatie towarzyszące nieswoistym zapaleniom jelit. Reumatologia 2007; 45: 148-153. .
 
11.
Rychlewska-Hańczewska A, Puszczewicz MJ, Kołczewska A. Współwystępowanie reumatoidalnego zapalenia stawów i zesztywniającego zapalenia stawów kręgosłupa u chorego na wrzodziejące zapalenie jelita grubego – opis przypadku. Reumatologia 2009; 46: 32-36. .
 
12.
Thjodleifsson B, Geirsson AJ, Björnson S, Bjarnason I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis. Arthritis Rheum 2007; 56: 2633-2639. .
 
13.
Fries W. Common immunologic mechanisms in inflammatory bowel disease and spondyloarthropathies. World J Gastroenterol 2009; 15: 2472-2478. .
 
14.
Amital H, Gershwin ME, Shoenfeld Y. Reshaping the mosaic of autoimmunity. Semin Arthritis Rheum 2006; 35: 341-342. .
 
15.
Shoenfeld Y, Gilburd B, Abu-Shakra M, et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. IMAJ 2008; 10: 3-7. .
 
16.
Reszczyńska M, Urbańczyk A, Łężyk E i wsp. Analiza manifestacji pozajelitowej nieswoistych zapaleń jelit u pacjentów w wieku rozwojowym. Pediatr Współcz Gastroenterol Hepatol Żywienie Dziecka 2008; 10: 137-142. .
 
17.
Ardizzone S, Bianchi PG. Biologic therapy for inflammatory bowel disease. Drugs 2005; 65: 2253-2286. .
 
18.
Triantafillidis JT, Merikas E, Georgopoulos F. Current and emerging drugs for the treatment of inflammatory bowel disease. Drug Des Devel Ther 2011; 5: 185-210.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top